Navigation Links
Sentry Logistic Solutions Launches Foreign Trade Zone Service

Unique Offering Provides Financial & Operational Advantages for Global Life

Science Companies

INDIANAPOLIS, Nov. 7 /PRNewswire/ -- Sentry Logistic Solutions today launched a Foreign Trade Zone (FTZ) Service targeting pharmaceutical and biotechnology companies engaged in international business. This FTZ Service fully integrates with Sentry's current services and creates significant financial advantages and supply chain efficiencies for life science organizations that import a high volume of materials such as active pharmaceutical ingredients (API), pharmaceutical manufacturing and packaging materials and biopharmaceutical components into the United States.

According to the Foreign Trade Zone Corporation, companies that utilize a FTZ can save up to 90 percent annually on import fees, depending upon the frequency of inventory shipments. Sentry's clients can benefit financially from inverted tariffs, duty exemption on re-exports, weekly entry savings and duty deferrals for importing a broad range of pharmaceutical and biotechnology materials and products. This FTZ Service provides additional advantages including increased confidence in product integrity; reduced utilization of internal resources; improved control of products awaiting customs clearance; and enhanced scalability for better managing fluctuating import volume.

The new FTZ Service features end-to-end import and export management of pharmaceutical and biotechnology products and components. Sentry helps its clients leverage the FTZ designation to their greatest advantage by creating a customized storage, logistics and distribution strategy that matches their specific import-export activity profile, financial objectives and product- handling requirements. As part of the FTZ Service, Sentry assesses, handles and facilitates proper U.S. customs documentation and procedures on behalf of its clients. It also stores and distributes its clients' products from its state-of-the-art 50,000 square foot cold chain storage and distribution center in Indianapolis.

"The international life science community will realize powerful gains from Sentry's Foreign Trade Zone Service," said Jennifer Marcum, Sentry's chief executive officer. "Pharmaceutical and biotechnology companies will benefit financially by utilizing our FTZ designation, and they will benefit operationally by leveraging our expertise in handling, storing and transporting temperature-controlled drug products and components. Our FTZ Service opens the door for this highly-regulated sector to finally reap the same advantages that manufacturers in more traditional industries have always enjoyed."

Sentry's strategic location in FTZ #72, covering the Indianapolis metropolitan area, makes it one of the only dedicated third party logistics providers for the life science sector with certified designation (FTZ #72 Sentry Logistic Solutions) in the United States. Additionally, Sentry's headquarters in Indianapolis also provides other logistical efficiencies including close proximity to five major interstate highways (allowing access to 75 percent of U.S. businesses within a 24-hour truck drive), the second largest U.S. FedEx hub and the Indianapolis International Airport.

Sentry's FTZ Service compliments the company's robust outsourced business model that allows it to play a variety of key roles for its clients, depending on their supply chain needs. This includes short-term, long-term, emergency and contingency storage, logistics and distribution programs utilizing refrigerated, frozen or ambient temperature conditions, as well as fully outsourced supply chain solutions.

About Sentry Logistic Solutions

Sentry Logistic Solutions is one of the few cGMP temperature-controlled storage and third party logistics (3PL) providers in the United States to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the warehousing, packaging and logistics needs of pharma and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in cold chain storage and logistics, quality assurance, pharmaceutical packaging and kitting development. Sentry also offers strategic solutions for domestic and international transportation and logistics as well as end-to-end import and export management. The company's validated processes and inventory tracking systems are FDA compliant, adhere to Good Manufacturing Practice (GMP) and comply with stringent standard operating procedures (SOP) outlined in Sentry's Validation Master Plan. Sentry is VAWD(R) accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Board of Pharmacy(R). The company is privately- held and strategically headquartered in Indianapolis, Ind. For more information about the company, please visit or call (866) 757-7400.


Rachel Edwards Amy Zucker

Synergy Marketing Group, Inc. Synergy Marketing Group, Inc.

(317) 205-9690 ext. 227 (317) 205-9690 ext. 223

SOURCE Sentry Logistic Solutions
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
2. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
3. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
4. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
5. BioLife Solutions Expands Scientific Advisory Board
6. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
9. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
10. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
11. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> Accutest Research Laboratories, ... Contract Research Organization (CRO), has formed ... Cancer Center - Temple Health for ... ,     (Photo: ) , ...
(Date:11/25/2015)... November 25, 2015 2 nouvelles études ... les différences entre les souches bactériennes retrouvées dans ... des êtres humains . Ces recherches  ouvrent une ... la prise en charge efficace de l,un des ... les chats .    --> 2 nouvelles ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
Breaking Biology Technology:
(Date:11/16/2015)... SAN JOSE, Calif. , Nov 16, 2015 ... leading developer of human interface solutions, today announced ... new Synaptics TouchView ™ touch controller and ... the architectural revolution of smartphones. These new TDDI ... and include TD4100 (HD resolution), TD4302 (WQHD resolution), ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):